5593064438 · Partihandel med medicinsk utrustning och apoteksvaror · BROMMA
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Net sales grew 28 % in 2025, reaching 25.7 MSEK. The company’s operating margin of 34.7 % exceeded three quarters of the 579 comparable companies in its industry. hameln pharma AB held cash corresponding to roughly 50.2 % of total assets at the period end. With 1 employees, net sales corresponded to roughly 25.7 MSEK per employee in 2025.
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
25.7 MSEK
▲ +28%Net result
7 MSEK
▲ +23%Employees
1
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.